squibb sqb not interested buying cetus robert fildes president and chief executive cetus corp ctus told reuters that squibb corp not interested buying cetus earlier companies squibb buy cetus pct equity postion cetus for mln dlrs this not attempt squibb become major majority holder cetus fildes told reuters interview squibb not approached indication that want acquire and wouldn interested that kind arrangement fildes squibb not reached comment late comments fildes squibb cetus pharmaceutical partner and equity position cetus eastman kodak and grace joint ventures cetus owns equity position company fildes cetus venture kodak develp diagnostic products and grace develop agricultural products earlier squibb and cetus announced joint statement agreement principle form joint venture develop biotechnology products fields part deal squibb will license cetus anticancer agents including interleukin development squibb will sell drugs japan and markets not north american and western europe wouldn this deal had not understood that cetus build fully integrated business north america and europe fildes squibb good partner squibb major joint venture japan and sales capabilities that market fildes cetus shunned licensing arrangements pharmaceutical companies wanted build business large corporations invested small biotech firms squibb investment cetus made biotechnology fildes that attractive cetus wanted partner that didn relationship large number biotechnology companies fildes strategy partners drug areas diagnostics and agriculture biggest developments anticancer drugs ourselves fildes partnership squibb used broaden company reach such big money making areas cardiovascular anti infective and anti inflammatory markets squibb investming mln dlrs cetus research years squibb putting mln dlrs research and development make happen equity position part package simply demonstrate seriousness this partnership fildes reuter
